Tidal Investments’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
TCM
O
SCM
ES
VC
PAI
Tidal Investments's CMPX Position: Q2 2026 in Review
Tidal Investments sold out of Compass Therapeutics (CMPX) in Q2 2026, closing a stake of 138,276 shares — an estimated $731K sold.
Tidal Investments first reported a position in CMPX in Q1 2026 and held it in 1 quarter. The position peaked at $731K in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.
- Tidal Investments reported no remaining Compass Therapeutics position as of Q2 2026 after selling out during the quarter.
- Tidal Investments sold 138,276 Compass Therapeutics shares in Q2 2026, an estimated $731K.
- Tidal Investments first reported a position in Compass Therapeutics in Q1 2026 and held it in 1 quarter.
- Tidal Investments's Compass Therapeutics position peaked at $731K in Q1 2026.
- 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.
Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.